






































Human embryonic stem cells (hESCs) are notable 
because they possess the ability to self-renew 
indefinitely and are capable of differentiating into all 
tissues of an organism.  These cells are able to preserve 
their genomic and epigenetic integrity to a higher 
degree than somatic cells [1]. ESCs may use several 
mechanisms to maintain genomic stability including the 
up-regulation of DNA repair, the utilization of high-
fidelity forms of repair, and the efficient elimination of 
damaged cells by apoptosis [2-5]. Unrepaired DNA 
double-strand breaks (DSBs) lead to toxic lesions, 
chromosomal aberrations and genomic instability that 
could give rise to cancer [6]. There are two major 
pathways for DSB repair in mammalian cells; 
homologous  recombination  repair (HRR)  and   non- 
 
 




































homologous end joining (NHEJ) [6]. Ataxia 
telangiectasia mutated (ATM), ATM and Rad3-related 
(ATR), and DNA-dependent protein kinase catalytic 
subunit (DNA-PKcs) are members of the PI3K-related 
kinase (PIKK) family that are activated by DNA 
damage and are associated with DNA damage check-
point signaling and preservation of genomic stability, 
with all three playing important roles in DSB repair. 
The form of DSB repair with the highest fidelity is HRR 
which utilizes homologous sequences from a sister 
chromatid, homologous chromosome, or repetitive 
sequence as templates for repairing the damaged DNA.   
 
NHEJ represents the more error-prone form of DSB 
repair with faster repair kinetics than HRR. 
Mechanistically this process begins with the binding of 
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holoenzyme. Before ligation the DNA ends are 
sometimes resected by the Artemis and/or 
MRE11/RAD50/NBS1 (MRN) nucleases, followed by 
XRCC4/DNA Ligase IV/XLF recruitment necessary for 
resealing [6, 7]. Several factors determine whether HRR 
or NHEJ is employed including stage of the cell cycle, 
growth factor signaling, and the severity and type of 
damage [6, 8].  
 
Interestingly, a backup NHEJ (B-NHEJ) pathway has 
been described that utilizes poly (ADP-ribose) 
polymerase-1 (PARP-1), histone H1, and Ligase 
III/XRCC1, but not DNA-PKcs as main components for 
sealing some DSBs [9, 10]. Some studies suggest that 
DNA-PKcs-dependent NHEJ (D-NHEJ) prevents loss 
of genetic information [11, 12], while the less 
conservative microhomology-mediated end joining 
(MMEJ) may occur to a greater extent when DNA-PK, 
and other proteins part of the canonical NHEJ, are 
absent [13, 14]. D-NHEJ reseals DSBs with faster repair 
kinetics possibly because the repair proteins have 
greater affinity for the DSB [9, 15]. Although the 
B-NHEJ pathway seems more critically dependent on 
micro-homology than classical NHEJ, gap-filling of 
aligned ends has not been observed for B-NHEJ in 
vitro, and the known NHEJ gap-filling polymerases μ 
and  λ appear to be specifically recruited by the 



























PARP-1 binds to DNA at damage sites and catalyses the 
formation of poly (ADP-ribose) (PAR) on itself and 
other acceptor proteins including histones [12, 18]. PAR 
formation is believed to alter chromatin structure, 
protect sites of DNA breaks and attract repair proteins. 
While knockout of either ATM or PARP-1 individually 
does not result in lethality, double knockouts are lethal 
[19].  This suggests that ATM and PARP-1 may act as 
backup to each other when DNA is faced with harmful 
DNA breaks.  In addition, it was shown that ATM and 
DNA-PKcs function in the same pathway to ensure cell 
survival in the absence of PARP-1 [20]. 
 
Early in mouse development there is preferential use of 
HRR compared to NHEJ [21, 22]. However, while 
correlative data suggest that NHEJ may exist in mESC, 
it is clear that there are differences between the human 
and mouse systems  [23, 24], and so far there has been 
no direct demonstration of NHEJ in hESCs.  Recent 
studies from our laboratory have demonstrated that 
HRR is utilized extensively by hESCs and that it 
decreases throughout differentiation to NPs and 
astrocytes [5].  Importantly, we showed that ATR is 
imperative for the regulation of DSB repair in hESCs 
without any apparent involvement of ATM. In support 
of our findings, it was recently shown that genetic 
manipulation of hESCs creating an ATM knockout by 
targeted allele disruption did not lead to significant 




























Schematic  of  the  NHEJ‐red  cassette.  (B)  Oct3/4  (green)  positive  hESCs  display  DsRed  (red)  48  h  after
infection with a multiplicity of infection (MOI) of 30 with Ad‐SceI adenovirus.  DAPI shows nuclear staining. 
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through specific lineages for therapeutic purposes. 
Preserving genomic stability in these cells is therefore 
very important and, thus, a better understanding of 
DNA repair processes occurring in these cells is critical. 
We report here that rapidly proliferating hESCs utilize 
NHEJ in a process that is ATM-independent and largely 
DNA-PKcs-independent  and show that upon 
differentiation of the hESCs to NPs and then astrocytes, 
the rate of NHEJ progressively increases whereas the 




hESCs utilize NHEJ for DSB repair  
 
Previous work demonstrated that hESCs are highly 
proliferative cells with strong G2 checkpoints and an 
absent G1 checkpoint [26].  For this reason it is believed 
hESCs would depend extensively on HRR. Indeed, we 
recently showed that hESCs form RAD51 foci, a marker 
for HRR, far more extensively and express RAD51 at 10-
fold higher levels than differentiated astrocytes [5].  We 
also demonstrated that the relative fast repair kinetics 
using  γ-H2AX foci as surrogate suggested that hESCs 
have NHEJ [5]. However, both γ-H2AX and 53BP1 foci 
resolution was relatively unresponsive to a small 
molecule inhibitor of DNA-PKcs kinase suggesting that 
NHEJ in hESCs is largely independent of DNA-PKcs 
[5]. To determine the nature of NHEJ in hESCs in more 
detail and to clarify the role of DNA-PKcs, we 
engineered the hESCs with a lentivirus (LV) carrying an 
I-SceI repair cassette that would make them more 





















BG01V cells were infected with the NHEJ-red LV and 
stable transductants selected in G418-supplemented 
medium.  A number of clones were isolated and 
expanded, and one was chosen for further study. The 
hESC clone was infected with the I-SceI expressing 
adenovirus and shown to be positive for Oct3/4 nuclear 
staining, indicating that the cells were hESCs, and 
positive for DsRed suggesting that they utilize NHEJ. 
Therefore, the hESCs use NHEJ since the production of 
DsRed after I-SceI adenoviral infection could only 
occur by NHEJ (Figure 1B). 
 
NHEJ detected by genomic DNA qPCR assay 
 
After validation of the fluorescence-based NHEJ assay 
by immunocytochemistry, we utilized a more rapid 
qPCR assay that also allows for determining NHEJ at 
earlier time points than by FACS [8]. Genomic DNA 
qPCR would be a more direct, quantitative method for 
determining NHEJ that eliminates transcriptional or 
translational effects that may influence fluorescent 
protein based DNA repair assays [8]. A time course 
after Ad-SceI infection showed an increase in NHEJ by 
SYBR-Green qPCR, and the 125-bp DNA fragment 
predicted to result from the removal of the 25-bp stuffer 
from the 150-bp fragment (Figure 2A).  Unexpectedly, 
the 125-bp repair product was amplified much more 
efficiently than the original uncut sequence, so that the 
repair product could be detected quantitatively by 
SYBR-Green qPCR. Using this assay a significant 139-
fold increase was detected in the I-SceI infected cells at 
24 h compared to uninfected cells (Figure 2B). These 
results demonstrate that hESCs have the ability to repair 



































































NHEJ levels correlate with differentiation 
 
Previous work from our group established optimal 
conditions for the growth and differentiation of hESCs 
on feeder-free cultures into NPs and astrocytes [5, 27, 
28].  We have not only shown a loss in proliferation 
after differentiation to astrocytes, but also changes in 
morphological and phenotypic properties such as 
increased glutamate uptake associated with astrocytes 
[27].  Since these cell populations are identical at the 
genetic level any changes observed are likely due to 
alterations in epigenetics.  Thus, it is possible that 
adenovirus infection and I-SceI expression may change 
through differentiation thus accounting for the 
differences seen in NHEJ. To determine the relative 
levels of I-SceI expression in these cell populations, 







































MOI of adenovirus expressing HA-tagged I-SceI. These 
three cell populations expressed very similar levels of 
HA-SceI (Figure 3A). This assay would therefore be 
able to accurately assess any changes in NHEJ repair 
through differentiation.  
 
In terms of NHEJ, as cells transitioned from hESCs to 
NPs there was a trend towards increased NHEJ, whereas 
astrocytes showed a 2.7-fold increase over hESCs when 
the PCR assay was utilized (Figure 3B). This result was 
supported by flow cytometry analysis determining the 
quantity of DsRed positive cells. At 48 h the astrocytes 
exhibited 2.6-fold more cells expressing DsRed than 
hESCs and at 72 h there was a 1.6-fold increase (Figure 
3C). This result shows that DsRed is produced faster in 
astrocytes and again that there is no difference between 











www.impactaging.com                    585                                   AGING,    September 2010, Vol.2 No.9results from the qPCR with that of flow cytometry it is 
unlikely that astrocytes have a greater ability to express 
the reporter. Combined, these results show a significant 
increase in the kinetics of NHEJ upon differentiation of 
the NPs to astrocytes. Therefore cell cycle stage, cell 
growth or various multi-potency factors may lead to a 
differential in the kinetics of, and perhaps also the type of 
NHEJ repair in these isogenic cell populations. 
 
ATM and DNA-PKcs kinases are not critical for 
NHEJ in hESCs 
 
We, and another group, showed recently that an ATMi 
was only partially effective at abrogating DSB repair 
and DNA damage checkpoint signaling in hESCs [5, 







































and KU-57788 (DNA-PKi) small molecule inhibitors 
were entering the cells, the effect on radiation-induced 
H2AX (S139) and KAP1 (S824) phosphorylation was 
examined. KAP1 is involved in chromatin remodeling 
after DNA damage and its activation is dependent on 
ATM and DNA-PKcs at early time points [29]. 
Furthermore, we showed recently that H2AX 
phosphorylation is completely blocked at early times (≤ 
15 min) after irradiation when both drugs are applied to 
glioma cells [30]. Here, we show that after irradiation p-
KAP1 and γ-H2AX are reduced to near basal levels in a 
time-dependent manner when treated with a 
combination of ATMi and DNA-PKi (Figure 4A). 
Therefore, we conclude that both drugs enter hESCs 
and inhibit the DDR similar to what is seen with glioma 









































































































We then determined the effect of these drugs on NHEJ 
using qPCR and show, in line with our previous results 
[5], that both ATMi and DNA-PKi were relatively 
ineffective at inhibiting NHEJ repair in hESCs with 
only 20-25% reduction observed (Figure 4B). However, 
there was significant inhibition of 40-50% in the 
presence of either one of these drugs in NPs (Figure 
4C). This inhibition becomes even more pronounced 
when these cells were further differentiated into 
astrocytes.  Here, NHEJ levels were reduced to 25% 
when cells were treated with the ATMi compared to 
untreated hESCs and to 27% when treated with the 
DNA-PKi (Figure 4D).  Altogether, these results 
suggest that NHEJ in hESCs is to a large extent 
independent on either ATM or DNA-PKcs. However, as 
hESCs differentiate to NPs and astrocytes, respectively, 
this dependency progressively increases.  
 
To more thoroughly investigate the relative 
ineffectiveness of the DNA-PKi on NHEJ in hESCs and 
to better understand DNA-PKcs’ role, we transfected 
the hESCs with siRNA targeting DNA-PKcs and then 
examined the impact on NHEJ.  hESCs transfected with 
DNA-PKcs siRNAs showed 90% knockdown of DNA-
PKcs levels at both 48 and 72 h (Figure 5A). It was also 
important to analyze the effect of this knockdown on 
adenoviral expression of I-SceI. DNA-PKcs knockdown 
did not affect the expression of HA-SceI (Figure 5B). 
However, only a reduction in NHEJ repair by ~30% 
was noted (Figure 5C), fully supporting the result with 
the DNA-PKi. A similar result was obtained with the 
qPCR assay at an earlier time point of 24 h (Figure 5D).  
Therefore, in hESCs DNA-PKcs appears to play only a 
minor role in NHEJ.  
 
Interfering with XRCC4 function impairs NHEJ 
 
Canonical NHEJ requires XRCC4/Ligase IV/XLF, 
which acts as a complex in the final ligation step [6]. 
XRCC4 is uniquely required for NHEJ and has no other 
known function than to promote gap-filling and 
resealing of DSBs during NHEJ. To determine whether 
repair of the NHEJ-red cassette requires XRCC4 we 
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compared to cells transfected with control siRNA at 
both 48 and 72 h, and repair levels to about 40% 
(Figure 6A and B), suggesting that XRCC4 and 
canonical NHEJ is the primary type of repair. Then, to 
verify this result we infected BG01V/NEJ-red cells 
with Ad-FlagXRCC4115-292 or Ad-EGFP (control) and 
first examined expression of the XRCC4 protein 
fragment.  Ad-FlagXRCC4115-292 expresses a decoy 
XRCC4 expected to inhibit NHEJ [31]. We found 












































correlating with the presence of a Flag-containing 
fragment of the correct size in the Ad-XRCC4 sample 
and not the Ad-EGFP sample (Figure 6C).  When 
NHEJ was examined, we observed a 50-60% reduction 
in repair in cells expressing truncated XRCC4, 
expected to interfere with XRCC4/Ligase IV function, 
compared to cells infected with Ad-EGFP (control) 
virus (Figure 6D). Thus, all combined, the primary 
type of NHEJ utilized in repairing the I-SceI DSB in 
our construct depends largely on XRCC4 and 

























































































High-fidelity NHEJ decreases as hESCs differentiate 
 
If hESCs rely on alternative forms of repair it is 
possible there would be a difference in the fidelity with 
which the repair occurs.  As hESCs differentiated to 
NPs and astrocytes there was a progressive decrease in 
the extent to which the overhangs were filled in with 
AA nucleotides indicating high-fidelity NHEJ.  hESCs 
displayed a 2.6-fold higher levels of high-fidelity NHEJ 
compared to astrocytes, whereas NPs displayed a 1.8-
fold increase compared to astrocytes (Figure 7 and 
Figure S1).  A U87 glioma cell clone carrying the 
NHEJ-red vector [8], showed a 1.3-fold higher level of 
high-fidelity NHEJ (data not shown) compared to in 
vitro derived astrocytes. In order to verify the results 
that the ability of PsiI to digest the 125-bp PCR product 
corresponds to high-fidelity NHEJ, DNA sequencing of 
the cloned PCR fragments was performed.  DNA 
sequencing revealed that 50% of the amplified DNA 
showed the presence of the PsiI site (Table 1 and Table 
S1), which correlates well with the ~55% obtained by 
PsiI digestion (Figure 7).  DNA changes included small 
deletions of 1-3 nucleotides but no larger deletions or 
any insertions were noted. In line with this finding, 
cloning and sequencing of PCR fragments from the 
U87/NHEJ-red cells showed a similar correlation 
between  PsiI digestion and DNA sequence analysis 
(data not shown).  Altogether, high-fidelity repair 
correlates with replicative growth and cell cycle 
distribution and was close to 3-fold higher in hESCs 
than in astrocytes and human glioma cells.   
Furthermore, our data suggest that when presented as an 
option partially complementary DNA overhangs are 
repaired without resection.  
 
PARP inhibition does not affect NHEJ but induces 
DSBs in hESCs 
 
 Our results so far suggests that rapidly dividing hESCs 
may rely extensively on a DNA-PKcs-independent but 
otherwise canonical NHEJ. Another type of NHEJ is a 
microhomology-mediated form of NHEJ (MMEJ) [10], 
therefore, inhibiting this pathway may reveal the 
process responsible for NHEJ repair in hESCs. PARP 
has been shown to be important for MMEJ in 
mammalian cells [9, 10] and therefore a highly specific 
PARP1/2 inhibitor, KU-54936 (PARPi) could be used 
to interrogate the possibility that MMEJ is important in 
hESCs [9, 10, 32].  In line with current knowledge that 
PARP inhibition induces DSBs in cancer cells, we show 
that the PARPi does so also in hESCs and NPs leading 
to increased γ-H2AX foci formation (Figure 8A). 
Despite the demonstration that the drug is active in 
these cells there was no effect on NHEJ (Figure 8B). 
Thus, PARP-1/2 does not seem to influence NHEJ in 
hESCs suggesting that B-NHEJ is not critical for repair 



































Sequence N  %  Deletion 
HiFi 
TTATAA  14 50  none 
Non-HiFi      
---ATAA 5  17.9 TT 
-TATAA 2  7.1  T 
TTAT--- 2  7.1 AA 
TTATA- 2  7.1  A 
TTA---A 2  7.1 AT 




























































Genomic instability has long been an important issue in 
cancer and cancer therapeutics but is now also 
becoming a focus for regenerative medicine therapies. 
Human embryonic stem cells propagated in culture 
develop aneuploidy and other DNA rearrangements 
over time that makes them unsuitable for clinical 
application. Thus, it is important to understand the 
mechanisms important for maintaining genomic 
stability in these cells and in the resulting descendants. 
This report is beginning to define the role of NHEJ in 
hESC and in neural cells as a model for studying the 
DDR and DSB repair in cells of normal human brain.  
 
Current understanding is that the spontaneous mutation 
rate is lower in embryonic stem cells compared to 
somatic cells suggesting that these cells have high 
capacity to repair DNA or that damaged cells easily die 
[1, 4]. There is a requirement for high-fidelity DNA 
repair in hESCs since they eventually would give rise to 
an entire organism. Gene knockout studies have 
demonstrated that mESC cells preferably utilize HRR 
rather than NHEJ as a principal mechanism of repair 
and we have demonstrated this holds true also in hESCs 
[5, 21].  It is well established that hESCs predominantly 
exist in the S/G2 phases of the cell cycle and have a 
shortened G1 phase where NHEJ dominates in somatic 
cells [26, 33].  Herein, we provide direct evidence that 
Oct3/4+ hESCs utilize NHEJ as a DSB repair 
mechanism. While hESCs employ the NHEJ machinery 
it appears to take a backup role to HRR [5], and the 
factors and features of this type of repair change 
through differentiation. Recent findings have suggested 
that there may be more than one type of NHEJ, with the 
predominant pathway utilizing DNA-PKcs, and a 
backup NHEJ pathway utilizing histone H1, PARP-1, 
and XRCC1/Ligase III [9, 10]. However, repair in 
hESCs seems to primarily use DNA-PKcs-independent 
NHEJ to support high-fidelity repair without any PARP 
involvement. Thus, B-NHEJ does not seem to play a 
major role in the repair of our cassette, however, due to 
the incomplete elimination of NHEJ when available 
XRCC4 was knocked down, we cannot rule out that B-
NHEJ is serving a back-up role which would only 
reveal itself when XRCC4/Ligase IV activity is 
completely eliminated.  
   
It is important to point out a clear distinction between 
our repair system and other systems examining MMEJ 
in that we have examined NHEJ when DNA resection is 
not required and the partial DNA homology resides in 
the I-SceI overhangs. Other studies have utilized 
substrates for which MMEJ would require resection to 
expose the micro-homology to facilitate ligation [34, 
Figure 8.  PARPi functions in hESC and induces repair
foci but does not affect NHEJ.  (A) PARPi inhibits PARP in




and  collected  at  24  h  after  Ad‐SceI  infection.  (Columns)
Relative  qPCR  levels  was  normalized  to  β‐actin;  (Error  bars)
SEM  of  three  samples.  No  statistical  significance  was  found
between treated and untreated sample. 
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were small deletions of 1-3 nucleotides and contained a 
very high level of fidelity. Thus, our study does not 
address what resection process is functioning in hESCs 
and neural descendant but rather suggests that when a 
DNA micro-homology is already present in the DNA 
overhangs, it can be efficiently used for gap filling and 
ligation without the need for prior resection. 
 
In examining the kinetics of repair and effects of cell 
cycle it was shown previously that B-NHEJ has slower 
repair kinetics and occurs more often in the S/G2 phase 
of the cell cycle with increased growth signaling greatly 
enhancing the use of B-NHEJ [36, 37]. Herein, we have 
provided evidence for an increased dependence on D-
NHEJ in astrocytes compared to the rapidly 
proliferating hESCs. Previously, we examined γ-H2AX 
foci formation and their resolution after irradiation as a 
surrogate for DSB repair. We showed that as cells 
advance from the embryonic to more differentiated 
states DSB repair occurred with faster kinetics and a 
dependence on ATR and HRR to a dependence on 
ATM for NHEJ [5].  While the irradiation-induced foci 
assay is an indirect method and surrogate for repair, in 
this report we provide direct evidence using an 
integrated repair cassette that NHEJ occurs with faster 
kinetics in non-dividing astrocytes than in hESCs and 
NPs in line with our previous report. 
 
Additionally, we show the ATM and DNA-PK 
inhibitors have little effect on NHEJ in hESCs but 
reduce repair in NPs, and even more so in astrocytes. It 
is possible that these kinase inhibitors may be 
ineffective since the B-NHEJ pathway may not utilize 
DNA-PK [10].  However, knockdown of DNA-PKcs in 
hESCs yielded similar results, suggesting that DNA-
PKcs may be helpful but not essential for repair. 
Although utilization of a B-NHEJ pathway cannot be 
excluded, the marked decrease in NHEJ seen in 
XRCC4-knockdown cells suggests that much of the 
high-fidelity repair seen in hESCs is carried out by the 
classical NHEJ pathway, even though it is DNA-PKcs-
independent. This result is in agreement with previous 
studies using DSB repair-deficient hamster cells  [35], 
and extracts thereof [38-41], which suggest that KU, 
XRCC4 and Ligase IV, but not DNA-PKcs, are strictly 
required for gap filling on aligned DSB ends, a process 
that is essential for high-fidelity repair of our I-SceI-
generated DSB.  In support of our findings, a similar 
conclusion was reached when mouse adipocyte 
progenitor cells (in which D-NHEJ is not functional) 
were induced to differentiate, and similarly to what we 
observe in hESCs, the D-NHEJ repair pathway was 
only operational after differentiation [42].   
 
It was not surprising that the specific PARPi had no 
effect on NHEJ in hESC since a similar conclusion was 
made previously using mESCs [43]. One possible 
explanation for the lack of an effect of PARPi in hESCs 
is that these cells are globally euchromatic and have 
elevated global transcription compared to NPs [44, 45].  
Therefore, they might not require modification of 
chromatin for repair, and, interestingly, ATM may only 
be required for a subset of DSBs associated with 
heterochromatin [46]. Our experiments only addressed 
whether PARP is important for resealing NHEJ as a 
process in the context of a I-SceI-induced break and not 
at stalled replication forks that might lead to DSBs [47]. 
However, the PARPi in our study was fully active on 
hESCs since numerous γ-H2AX foci were seen after 
exposure to the drug indicating that PARP-1/2 does not 
affect DNA-PKcs-independent NHEJ in hESCs. 
 
Our previous study showed that hESCs rely extensively 
on high-fidelity HRR [5]. One possible explanation for 
the high-fidelity of NHEJ in S or G2 cells is the 
presence of sister chromatids, which have close physical 
cohesion that might play an important role in stabilizing 
the ends of the DSB and preventing degradation or 
exonuclease activity that leads to deletions [48].   
Therefore, this high-fidelity repair may serve as backup 
should HRR fail and the fidelity may increase from the 
presence of ATR and other factors only available in S 
and G2. Alternatively, if NHEJ of the I-SceI break 
primarily occurs outside of S and G2, for example in the 
compressed G1 phase, PARP may not serve a critical 
function. 
 
In summary, NHEJ occurs in hESCs but with slower 
kinetics than in astrocytes and with a greater extent of 
high-fidelity repair which is only partially affected by 
the inhibition of either the ATM or DNA-PKcs kinases.  
A large fraction of this NHEJ was dependent on 
XRCC4 and thus would be considered canonical NHEJ. 
In addition, we were unable to find any involvement of 
PARP and B-NHEJ in this repair suggesting that NHEJ 
in hESCs may have unique properties compared to 




Cell culture and treatments.  The human ESC line 
BG01V (ATCC, Rockville, MD) was cultured and 
differentiated on a feeder free system. BG01V cells are 
a derivative of BG01 cells with karyotypic ab-
normalities (49, +12, +17 and XXY) which retain 
embryonic stem cell markers and characteristics, and 
the ability to differentiate down a neural lineage [49]. 
Differentiation was performed to according to published 
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[5, 27, 50]. See Supplemental Materials and Methods.  
 
Antibodies and reagents.  Antibodies used were anti-
Oct3/4, -Chk1 and -β-actin from Santa Cruz 
Biotechnology (Santa Cruz, CA), anti-Nestin, -γ-H2AX 
(clone JBW301), -GFAP, and -Sox2, -Musashi1, -βIII-
tubulin, -O1 from Chemicon/Millipore (Billerica, MA), 
anti-p(S824) KAP1 from Bethyl Laboratories 
(Montgomery, TX), and anti-HA from Cell Signaling 
(Danvers, MA).  KU-55933 (ATMi), KU-57788 (DNA-
PKi), KU-59436 (PARPi) were kindly provided by 
Mark O’Connor (KuDOS Pharmaceuticals Ltd, 
Cambridge, United Kingdom) [32, 51, 52]. All drugs 
were dissolved in DMSO. PsiI was purchased from 
New England Biolabs (Ipswich, MA). 
 
Western blotting and immunocytochemistry.  Immuno-
cytochemistry and imaging has been described 
previously [5, 53]. Western blotting was performed as 
described [5, 30, 53]. 
 
NHEJ repair.  BG01V/NHEJ-red cells were isolated by 
infection of BG01V cells with a lentivirus (WPXLd-
2xISceI-DsRed-IRES-NEO) harboring a repair cassette 
(hereafter referred to as NHEJ-red) positioned upstream 
of the DsRed reporter gene that was recently described 
(see Supplemental Methods in [8]), with the exception 
that an IRES-NEO selection cassette was added (Figure 
1A). Cells resistant to G418 were cloned by dilution and 
screened for the integration of NHEJ-red  by infection 
with adenovirus expressing the I-SceI endonuclease 
from Saccharomyces cerevisiae (Ad-SceI) [8], followed 
by subsequent analysis of DsRed expression. The 
NHEJ-red assay is build on a repair cassette having two 
I-SceI recognition sequences flanking an ATG codon 
that acts as a decoy preventing translation of the DsRed 
reporter. Upon cleavage with I-SceI the decoy codon is 
excised within a 25-bp stuffer fragment.  If NHEJ takes 
place the DNA is sealed and DsRed is expressed from a 
downstream previously out-of-frame ATG codon (see 
Figure 1A).   
 
To induce cleavage of NHEJ-red cassette, Ad-SceI (30-
100 MOI) was added to the culture medium and cells 
incubated with virus while slowly rocking for 6 h at 
37°C, and then cells were collected at indicated time 
points for repair analysis. The two I-SceI recognition 
sites are in opposite orientations, such that when both 
are cleaved with I-SceI and the stuffer fragment of the 
vector is excised, two partially complementary 3′ 
overhangs are generated: -TTAT (5′ → 3′) and TATT- 
(3′  → 5 ′).  If the generated partially complementary 
ends anneal without DNA-end resection, a two-base gap 
will result on both strands which could be filled in by a 
gap-filling polymerase.  This scenario would result in a 
repair joint with sequence -TTATAA-, which we define 
as high-fidelity NHEJ.  More extensive resection would 
still result in DsRed expression unless the deletion is so 
extensive that it removes the downstream DsRed ATG 
codon or removes the upstream promoter.  NHEJ events 
are then determined by FACS of DsRed positive cells 
and/or genomic qPCR, or by cloning and DNA 
sequencing. Flow cytometry was performed on live 
cells on a Beckman Coulter XL-MC flow cytometer at 
the Massey Cancer Center Flow Cytometry Facility. 
Cells infected with Ad-FlagXRCC4115-292 express a 
truncated version of human XRCC4 that acts as a decoy 
and presumably interferes with NHEJ resulting in 
radiosensitization of breast carcinoma cells [31]. 
BG01V/NHEJ-red cells were infected with either Ad-
FlagXRCC4115-292 or Ad-EGFP (control) at an estimated 
MOI of 30 and after 24 h infected or not with Ad-SceI. 
Twenty-four hours later cells were collected for qPCR 
repair assay and in a parallel set stained with anti-Flag 
antibody followed by Alexa-546-conjugated anti-mouse 
secondary antibody.   
 
Real-time qPCR assay and PsiI  digestion.  Genomic 
DNA was extracted using the High Pure PCR Template 
Preparation Kit (Roche).  Amplification of genomic 
DNA was performed on an ABI 7900HT Real-time 
qPCR instrument using SYBR Green (ABI, Foster City, 
CA). Relative NHEJ levels were determined after 
normalizing to β-actin levels. The PCR primers used for 
the NHEJ quantification were 5′-CACGAGACTAGCC 
TCGAGGTTT, 5′-CTTGAAGCGCATGAACTCCTT, 
and for β-actin  were 5′-TCACCCACACTGTGCCCAT 
CTACGA, and 5′-CAGCGGAACCGCTCATTGCCAA 
TGG (synthesized by the VCU Massey Cancer Center 
Nucleic Acids Research Facility). In addition to 
quantitative SYBR Green PCR, bands were also 
separated on a 9% non-denaturing polyacrylamide gel, 
detected by ethidium bromide staining, and imaged on a 
Typhoon 9410 variable mode scanner (General Electric 
Healthcare).  When amplifying genomic samples to be 
digested with PsiI, Amplitaq Gold Master mix (ABI, 
Foster City, CA) was used.  The samples were then 
digested with PsiI.  PsiI digestion of the 125-bp PCR 
fragment generates 77- and 48-bp fragments. Digested 
bands were separated on a non-denaturing poly-
acrylamide gel, stained and imaged as described above.  
Densitometric values were quantified using the 
QuantityOne analysis software (Bio-Rad), taking into 
account the relative size of each fragment.  
 
DNA sequencing.   PCR fragments were cloned and 
sequenced to determine repair fidelity.  DNA was 
cloned using the TOPO TA Cloning kit (Invitrogen) as 
described by the manufacturer’s instructions and 
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Kit.  DNA sequencing of the plasmids with M13 reverse 
universal primer was performed by the VCU Nucleic 
Acids Research Facility.  
 
Knockdown.  DNA-PKcs, ATR, and XRCC4 
expression was knocked down using the Smartpool 
siGENOME Cat# M-005030-01-05, M-003202-05, and 
M-004494-02, respectively. A GFP (5’-GAACGGCAU 
CAAGGUGAACdTdT-3’), or non-targeting siRNA (D-
001210-01-05) was used as a control. All siRNAs were 
purchased from Dharmacon. hESCs were nucleofected 
using program A-023 (Lonza Nucleofector II) and 
Nucleofector Embryonic Stem Cell Kit II solution with 
200 nM siRNAs according to the manufacturer’s 
recommendations as described previously [5]. 
 
Statistics.  Unpaired two-tailed t-tests were carried out 
on  ≥ triplicate data sets using GraphPad Prism 3.0 
(GraphPad Software, Inc.). P-values are indicated as 
follows: * <0.05; ** <0.01; *** <0.001, ns = not 
significant.  Error bars depict SEM for ≥ triplicate data 
sets. Statistical significance is marked in all figures 
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Cell culture and treatments.  BG01V cells are 
embryonic stem cells that are easier to culture than 
BG01 cells without inadvertently causing cell 
differentiation. They are a derivative of BG01 cells with 
karyotypic abnormalities (49, +12, +17 and XXY) 
which retain embryonic stem cell markers and 
characteristics, and the ability to differentiate down a 
neural lineage [49]. Differentiation was performed 
according to published protocols to obtain populations 
of NPs and astrocytes [5, 27, 50]. Briefly, BG01V cells 
were cultured in ES medium as described in [27, 54] 
consisting of Dulbecco’s
  modified Eagle’s medium 
(DMEM)/F12 medium (GIBCO, Grand
  Island, NY) 
supplemented with 20% knockout serum replacement 
(KSR) (GIBCO), 2 mM
  L-glutamine, 0.1 mM non-
essential amino
  acids, 50 U/ml penicillin, 50 µg/ml 
streptomycin, 0.1 mM β-mercapto-ethanol, and 5 ng/ml
 
basic fibroblast growth factor (b-FGF) (R & D Systems, 
Minneapolis, MN). Cells were expanded on dishes of 
decellularized MEF feeders. Derivation of NPs was 
performed as described [54]. Briefly, cells were grown 
on laminin coated dishes in DMEM/F12 medium 
containing 15% FBS and 5% KSR followed by an 
additional 7 days in media containing (DMEM/F12, N2 
supplement (GIBCO), penicillin/streptomycin, L-
glutamine, 5 ng/mL of b-FGF, and 10 ng/mL leukemia 
inhibitory factor (LIF). The cells were cultured in DN2 
media for an additional 7 days to obtain the NP 
population. NPs were propagated on poly-ornithine- and 
laminin-coated plates in Neurobasal A Medium
 
(GIBCO) supplemented with B-27 (GIBCO), L-
glutamine, and
  penicillin/streptomycin, 20 ng/mL b-
FGF, and 10 ng/mL of LIF. Astrocytes were obtained 
by exposure of NPs to DMEM and FBS for 25 days on 
laminin-coated plates as described [27, 50]. 
 
Cells were grown on Lab-Tek (Naperville, IL) glass 
slides. After treatment, cells were fixed with 3% 
paraformaldehyde, permeabilized with 0.5% Triton-X-
100 in phosphate-buffered saline (PBS) and blocked 
with 10% non-fat dry milk/0.5% goat serum/PBS prior 
to exposure to primary antibodies. Subsequently, cells 
were incubated with primary antibodies at dilutions of 
1:500 or isotype control non-specific sera (Chemicon) 
overnight at 4°C in the blocking solution, followed by 
secondary antibodies Alexa 488 goat anti-rabbit or goat 
anti-mouse 546 Fab fragment (Invitrogen) at 1:500 
dilution, and nuclei counter-stained with DAPI at 1 
μg/mL. Cells were imaged and analyzed using a Zeiss 
LSM 510 Meta imaging system in the Massey Cancer 
Center Flow Cytometry and Imaging Facility with a 























Figure  S1.  High‐fidelity  NHEJ  decreases  through  dif‐
ferentiation.  hESCs,  NPs,  and  astrocytes  samples  were
visualized  on  9%  polyacrylamide  gels  stained  with  ethidium
bromide. High‐fidelity NHEJ was determined by quantification of
the PCR amplified DNA resistant and sensitive to PsiI digestion
(PsiI‐sensitive)  over  that  of  the  undigested  DNA  and  the
densitometry was adjusted based on the difference in length of
each fragment. 125‐ and 75‐bp indicate DNA size markers, and
Control  +  and ‐  indicate  unrelated  samples  infected  or  not
infected with Ad‐SceI, respectively. 
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